Could a heart drug ease chest pain from tiny vessel disease?
NCT ID NCT06239974
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 23 times
Summary
This study tests whether the drug vericiguat can improve blood flow in the small vessels of the heart and reduce chest pain. It involves 94 adults aged 40-75 who have stable chest pain but no major blockages in their heart arteries. Participants will receive either vericiguat or a placebo, and researchers will measure changes in heart blood flow using MRI scans and exercise tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEST PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.